FDA names top IT staffer
This article was originally published in The Tan Sheet
Jim Rinaldi appointed chief information officer at FDA effective Dec. 29, following his five-month stint leading agency's IT consolidation effort. Rinaldi has held senior IT positions at the IRS and Marriott, agency says. Announcement, which came Jan. 6, follows December appointment of Linda Burek as CDER Office of Information Technology acting director...
You may also be interested in...
The independent, family-controlled German group has signed a third R&D pact with Danish biotech Gubra to develop poly-agonist peptides for obesity.
Inovio Pharmaceuticals has reported promising initial data from its first Phase III study of its electrical current-driven DNA plasmid-based immunotherapy, VGX-3100, in virus-associated cervical dysplasia; it is heading a small group of companies evaluating novel therapies in the condition, which often advances to cancer.
In the month ahead, a key ANDA approval could come for Viatris, while additional competition to Gilead Sciences’ Truvada for PrEP is on the way in the US following Teva and Amneal’s launches.